Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Unknown 5Recruiting 4Withdrawn 3Completed 3Active not recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Thoracic 1Dermatologic 1

Conditions

Neuroblastoma 1Melanoma 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Spermine Synthase × Clear all
NCT02145910 2025-05-02

Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

Thomas Jefferson University

Phase 1 Withdrawn
CNSDermatologic

Brain Neoplasms, Melanoma

NCT03406273 2023-09-28

Standardized Protocol of Surgery and Radiation for Patients With Brain Metastases in Relapsed Neuroblastoma

Milton S. Hershey Medical Center

Phase NA Withdrawn
CNS

Neuroblastoma

NCT02950792 2017-08-25

MRI Adaptive Replanning Using ViewRay

University of Miami

Phase NA Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡